INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 283 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,683,172 | -16.7% | 211,359 | +7.4% | 0.18% | -14.2% |
| Q2 2023 | $8,026,320 | +14.3% | 196,820 | +4.5% | 0.20% | +7.9% |
| Q1 2023 | $7,020,929 | +15.9% | 188,380 | +8.5% | 0.19% | +9.9% |
| Q4 2022 | $6,058,858 | -32.7% | 173,656 | +1.0% | 0.17% | -38.4% |
| Q3 2022 | $9,000,000 | +3.9% | 171,854 | +2.7% | 0.28% | +7.3% |
| Q2 2022 | $8,661,000 | +40.4% | 167,326 | +97.0% | 0.26% | +53.8% |
| Q1 2022 | $6,171,000 | -34.4% | 84,921 | +6.8% | 0.17% | -32.9% |
| Q4 2021 | $9,405,000 | +58.5% | 79,543 | +79.8% | 0.25% | +43.2% |
| Q3 2021 | $5,935,000 | +1645.6% | 44,245 | +2006.9% | 0.18% | +1660.0% |
| Q2 2021 | $340,000 | -89.2% | 2,100 | -98.1% | 0.01% | -94.7% |
| Q3 2018 | $3,155,000 | +6.9% | 110,239 | +2.2% | 0.19% | +5.6% |
| Q2 2018 | $2,952,000 | +29.1% | 107,912 | -0.5% | 0.18% | +29.9% |
| Q1 2018 | $2,287,000 | +17.5% | 108,425 | +7.1% | 0.14% | +20.2% |
| Q4 2017 | $1,946,000 | – | 101,230 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |